|
1
|
Benjamin EJ, Virani SS, Callaway CW,
Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling
FN, Deo R, et al: Heart disease and stroke statistics-2018 update:
A report from the American heart association. Circulation. 137. pp.
e67–e492. 2018, View Article : Google Scholar
|
|
2
|
Vita JA and Keaney JF Jr: Endothelial
function: A barometer for cardiovascular risk? Circulation.
106:640–642. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trpkovic A, Resanovic I, Stanimirovic J,
Radak D, Mousa SA, Cenic-Milosevic D, Jevremovic D and Isenovic ER:
Oxidized low-density lipoprotein as a biomarker of cardiovascular
diseases. Crit Rev Clin Lab Sci. 52:70–85. 2015. View Article : Google Scholar
|
|
4
|
Zhou F, Yang Y and Xing D: Bcl-2 and
Bcl-xL play important roles in the crosstalk between autophagy and
apoptosis. FEBS J. 278:403–413. 2011. View Article : Google Scholar
|
|
5
|
Menghini R, Stohr R and Federici M:
MicroRNAs in vascular aging and atherosclerosis. Ageing Res Rev.
17:68–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fichtlscherer S, De Rosa S, Fox H,
Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T,
Müller-Ardogan M, et al: Circulating microRNAs in patients with
coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cipollone F, Felicioni L, Sarzani R,
Ucchino S, Spigonardo F, Mandolini C, Malatesta S, Bucci M,
Mammarella C, Santovito D, et al: A unique microRNA signature
associated with plaque instability in humans. Stroke. 42:2556–2563.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li P, Yin YL, Guo T, Sun XY, Ma H, Zhu ML,
Zhao FR, Xu P, Chen Y, Wan GR, et al: Inhibition of aberrant
MicroRNA-133a expression in endothelial cells by statin prevents
endothe-lial dysfunction by targeting GTP cyclohydrolase 1 in vivo.
Circulation. 134:1752–1765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xing SS, Yang XY, Zheng T, Li WJ, Wu D,
Chi JY, Bian F, Bai XL, Wu GJ, Zhang YZ, et al: Salidroside
improves endothelial function and alleviates atherosclerosis by
activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
Vascul Pharmacol. 72:141–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Panossian A, Hamm R, Wikman G and Efferth
T: Mechanism of action of Rhodiola, salidroside, tyrosol and
triandrin in isolated neuroglial cells: An interactive pathway
analysis of the down-stream effects using RNA microarray data.
Phytomedicine. 21:1325–1348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang YJ, Zhao GA, Lin F, et al: Research
progress on anti-atherosclerotic mechanism of salidroside. Chin J
Arteriosclerosis. 6:547–552. 2019.In Chinese.
|
|
12
|
Tang Y, Vater C, Jacobi A, Liebers C, Zou
X and Stiehler M: Salidroside exerts angiogenic and cytoprotective
effects on human bone marrow-derived endothelial progenitor cells
via Akt/mTOR/p70S6K and MAPK signalling pathways. Br J Pharmacol.
171:2440–2456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Zhang X, Zhang Y, Hu Z, Yang D,
Wang C, Guo M and Cai Q: Identification of miRNomes in human
stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic
target for gastric cancer. Cancer Lett. 369:58–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y,
Wang Z, Wang Z, Cheng P, Tong D, et al: MicroRNA-133a,
downregulated in osteosarcoma, suppresses proliferation and
promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 56:220–226.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma J, Wang T, Guo R, Yang X, Yin J, Yu J,
Xiang Q, Pan X, Zu X, Peng C, et al: MicroRNA133a and microRNA326
co-contribute to hepatocellular carcinoma 5-fluorouracil and
cisplatin sensitivity by directly targeting B-cell lymphoma-extra
large. Mol Med Rep. 12:6235–6240. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Qin B, Shu Y, Long L, Li H, Men X, Feng L,
Yang H and Lu Z: MicroRNA-142-3p induces atherosclerosis-associated
endothelial cell apoptosis by directly targeting rictor. Cell
Physiol Biochem. 47:1589–1603. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu K, Liu P and Zhao Y: Upregulation of
microRNA-876 induces endothelial cell apoptosis by suppressing
Bcl-Xl in development of atherosclerosis. Cell Physiol Biochem.
42:1540–1549. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar :
|
|
20
|
Eulalio A, Huntzinger E and Izaurralde E:
Getting to the root of miRNA-mediated gene silencing. Cell.
132:9–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shimizu S, Takehara T, Hikita H, Kodama T,
Miyagi T, Hosui A, Tatsumi T, Ishida H, Noda T, Nagano H, et al:
The let-7 family of microRNAs inhibits Bcl-xL expression and
potentiates sorafenib-induced apoptosis in human hepatocellular
carcinoma. J Hepatol. 52:698–704. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo R, Wang Y, Shi WY, Liu B, Hou SQ and
Liu L: MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces
cell apoptosis in SW1990 pancreatic cancer cells through
mitochondria mediated pathway. Molecules. 17:14733–14747. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu S, Huang H, Deng G, Xie Z, Ye Y, Guo R,
Cai X, Hong J, Qian D, Zhou X, et al: miR-326 targets antiapoptotic
Bcl-xL and mediates apoptosis in human platelets. PLoS One.
10:e01227842015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Schiff D, Park D and Abounader R:
MicroRNA-608 and microRNA-34a regulate chordoma malignancy by
targeting EGFR, Bcl-xL and MET. PLoS One. 9:e915462014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choy JC, Granville DJ, Hunt DW and McManus
BM: Endothelial cell apoptosis: Biochemical characteristics and
potential implications for atherosclerosis. J Mol Cell Cardiol.
33:1673–1690. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kavurma MM, Bhindi R, Lowe HC, Chesterman
C and Khachigian LM: Vessel wall apoptosis and atherosclerotic
plaque instability. J Thromb Haemost. 3:465–472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shamas-Din A, Kale J, Leber B and Andrews
DW: Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb
Perspect Biol. 5:a0087142013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Galluzzi L, Kepp O, Trojel-Hansen C and
Kroemer G: Mitochondrial control of cellular life, stress, and
death. Circ Res. 111:1198–1207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen HC, Kanai M, Inoue-Yamauchi A, Tu HC,
Huang Y, Ren D, Kim H, Takeda S, Reyna DE, Chan PM, et al: An
interconnected hierarchical model of cell death regulation by the
BCL-2 family. Nat Cell Biol. 17:1270–1281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fuchsluger TA, Jurkunas U, Kazlauskas A
and Dana R: Anti-apoptotic gene therapy prolongs survival of
corneal endothelial cells during storage. Gene Ther. 18:778–787.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qin B, Xiao B, Liang D, Li Y, Jiang T and
Yang H: MicroRNA let-7c inhibits Bcl-xl expression and regulates
ox-LDL-induced endothelial apoptosis. BMB Rep. 45:464–469. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun X, He S, Wara AKM, Icli B, Shvartz E,
Tesmenitsky Y, Belkin N, Li D, Blackwell TS, Sukhova GK, et al:
Systemic delivery of microRNA-181b inhibits nuclear factor-κB
activation, vascular inflammation, and atherosclerosis in
apolipoprotein E-deficient mice. Circ Res. 114:32–40. 2014.
View Article : Google Scholar
|
|
33
|
Loyer X, Potteaux S, Vion AC, Guérin CL,
Boulkroun S, Rautou PE, Ramkhelawon B, Esposito B, Dalloz M, Paul
JL, et al: Inhibition of microRNA-92a prevents endothelial
dysfunction and atherosclerosis in mice. Circ Res. 114:434–443.
2014. View Article : Google Scholar
|
|
34
|
Schober A, Nazari-Jahantigh M, Wei Y,
Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H,
Hristov M, et al: MicroRNA-126-5p promotes endothelial
proliferation and limits atherosclerosis by suppressing Dlk1. Nat
Med. 20:368–376. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Y, Qin W, Zhang L, Wu X, Du N, Hu Y,
Li X, Shen N, Xiao D, Zhang H, et al: MicroRNA-26a prevents
endothelial cell apoptosis by directly targeting TRPC6 in the
setting of atherosclerosis. Sci Rep. 5:94012015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma J, Yang S, Ma A, Pan X, Wang H, Li N,
Liu S and Wu M: Expression of miRNA-155 in carotid atherosclerotic
plaques of apolipoprotein E knockout (ApoE−/−) mice and
the interventional effect of rapamycin. Int Immunopharmacol.
46:70–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Han BH, Seo CS, Yoon JJ, Kim HY, Ahn YM,
Eun SY, Hong MH, Lee JG, Shin HK, Lee HS, et al: The inhibitory
effect of ojeoksan on early and advanced atherosclerosis.
Nutrients. 10:12562018. View Article : Google Scholar :
|
|
38
|
Yu H, Lu Y, Li Z and Wang Q: microRNA-133:
Expression, function and therapeutic potential in muscle diseases
and cancer. Curr Drug Targets. 15:817–828. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen JF, Mandel EM, Thomson JM, Wu Q,
Callis TE, Hammond SM, Conlon FL and Wang DZ: The role of
microRNA-1 and microRNA-133 in skeletal muscle proliferation and
differentiation. Nat Genet. 38:228–233. 2006. View Article : Google Scholar
|
|
40
|
Law IK and Pothoulakis C: MicroRNA-133α
regulates neurotensin-associated colonic inflammation in colonic
epithelial cells and experimental colitis. RNA Dis. 2:e4722015.
|
|
41
|
Zhang BC, Li WM, Guo R and Xu YW:
Salidroside decreases atherosclerotic plaque formation in
low-density lipoprotein receptor-deficient mice. Evid Based
Complement Alternat Med. 2012:6075082012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang LP: Effect of salidroside on
atherosclerosis induced by intermittent hypobaric hypoxia in
ApoE-/-mice. Chin J Arteriosclerosis. 7:675–679. 2014.In
Chinese.
|
|
43
|
Zhu Y, Zhang YJ, Liu WW, Shi AW and Gu N:
Salidroside suppresses HUVECs cell injury induced by oxidative
stress through activating the Nrf2 signaling pathway. Molecules.
21:10332016. View Article : Google Scholar
|
|
44
|
Zhu L, Jia F, Wei J, Yu Y, Yu T, Wang Y,
Sun J and Luo G: Salidroside protects against homocysteine-induced
injury in human umbilical vein endothelial cells via the regulation
of endoplasmic reticulum stress. Cardiovasc Ther. 35:33–39. 2017.
View Article : Google Scholar
|
|
45
|
Liu L, Zhang S and Zhang MQ: Protective
effect and mechanism of salidroside on endothelial cell surface
injury induced by high glucose. Chin Herb Med. 40:949–952. 2017.In
Chinese.
|
|
46
|
Ni J, Li Y, Li W and Guo R: Salidroside
protects against foam cell formation and apoptosis, possibly via
the MAPK and AKT signaling pathways. Lipids Health Dis. 16:1982017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhuang X, Maimaitijiang A, Li Y, Shi H and
Jiang X: Salidroside inhibits high-glucose induced proliferation of
vascular smooth muscle cells via inhibiting mitochondrial fission
and oxidative stress. Exp Ther Med. 14:515–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhao X, Jin L, Shen N, Xu B, Zhang W, Zhu
H and Luo Z: Salidroside inhibits endogenous hydrogen peroxide
induced cytotoxicity of endothelial cells. Biol Pharm Bull.
36:1773–1778. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu MC, Shi HM, Wang H and Gao XF:
Salidroside protects against hydrogen peroxide-induced injury in
HUVECs via the regulation of REDD1 and mTOR activation. Mol Med
Rep. 8:147–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
